Albireo Pharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
STEINER SOLOMON director
Common Stock 126,388 $1.99 $251,512
Sale
STEINER SOLOMON director
Common Stock 120,000 $2.03 $243,600
Sale
STEINER ERIK officer: Vice-President, Operat..
Common Stock 10,000 $2.08 $20,800
Sale
BAVIER PAUL S officer: General Counsel
Common Stock 3,658 $2.04 $7,462
Option
STEINER ERIK officer: Vice-President, Operat..
Common Stock 1,250 N/A N/A
Option
KRASNER ALAN SETH officer: Chief Medical Officer
Restricted Stock Units 12,850 N/A N/A
Option
BAVIER PAUL S officer: General Counsel
Common Stock 10,450 N/A N/A
Option
KRASNER ALAN SETH officer: Chief Medical Officer
Common Stock 12,850 N/A N/A
Option
MICHEL GERARD J officer: CFO, VP of Corp and De..
Restricted Stock Unit 11,600 N/A N/A
Sale
MICHEL GERARD J officer: CFO, VP of Corp and De..
Common Stock 4,000 $2.05 $8,200
Option
MICHEL GERARD J officer: CFO, VP of Corp and De..
Common Stock 11,600 N/A N/A
Option
STEINER ERIK officer: Vice-President, Operat..
Restricted Stock Unit 1,250 N/A N/A
Sale
STEINER SOLOMON director
Common Stock 57,367 $1.77 $101,540
Sale
STEINER SOLOMON director
Common Stock 67,633 $1.74 $117,681
Purchase
SANDERS CHARLES A director
Common Stock 5,000 $5.59 $27,950
Option
BAVIER PAUL S officer: General Counsel
Common Stock 5,423 $1.94 $10,521
Option
BAVIER PAUL S officer: General Counsel
Employee Stock Option (right to buy) 5,423 $1.94 $10,521
Sale
WEISMAN SCOTT director
Common Stock 40,000 $4.5 $180,000
Sale
KROIN DAVID director
Common Stock 65,574 $5.09 $333,772
Sale
KROIN DAVID director
Common Stock 17,671 $5.01 $88,532
Sale
KROIN DAVID director
Common Stock 34,010 $5.06 $172,091
Sale
KROIN DAVID director
Common Stock 35,200 $5.01 $176,352
Sale
KROIN DAVID director
Common Stock 78,890 $5.06 $399,183
Sale
WEISMAN SCOTT director
Common Stock 22,500 $4.92 $110,700
Option
BAVIER PAUL S officer: General Counsel
Restricted Stock Unit 10,450 N/A N/A
Option
KRASNER ALAN SETH officer: Chief Medical Officer
Common Stock 3,100 $1.94 $6,014
Option
KRASNER ALAN SETH officer: Chief Medical Officer
Employee Stock Option (right to buy) 3,100 $1.94 $6,014
Sale
KROIN DAVID director
Common Stock 1,300 $5 $6,500
Sale
WEISMAN SCOTT director
Common Stock 7,500 $5 $37,500
Sale
KROIN DAVID director
Common Stock 3,267 $5.02 $16,400
Sale
KROIN DAVID director
Common Stock 7,000 $5.03 $35,210
Sale
KROIN DAVID director
Common Stock 7,600 $5.08 $38,608
Sale
KROIN DAVID director
Common Stock 9,400 $5.19 $48,786
Sale
KROIN DAVID director
Common Stock 7,500 $5.26 $39,450
Sale
KROIN DAVID director
Common Stock 9,059 $5.23 $47,379
Sale
KROIN DAVID director
Common Stock 4,404 $5.12 $22,548
Sale
KROIN DAVID director
Common Stock 18,600 $5.14 $95,604
Sale
KROIN DAVID director
Common Stock 7,413 $5.29 $39,215
Sale
KROIN DAVID director
Common Stock 11,319 $5.25 $59,425
Sale
KROIN DAVID director
Common Stock 4,600 $5.17 $23,782
Sale
KROIN DAVID director
Common Stock 3,995 $5.16 $20,614
Sale
KROIN DAVID director
Common Stock 5,800 $5.23 $30,334
Sale
KROIN DAVID director
Common Stock 5,835 $5.21 $30,400
Sale
WEISMAN SCOTT director
Common Stock 3,851 $5.25 $20,218
Sale
WEISMAN SCOTT director
Common Stock 4,249 $5.25 $22,307
Sale
KROIN DAVID director
Common Stock 8,300 $5.22 $43,326
Sale
KROIN DAVID director
Common Stock 5,200 $5.23 $27,196
Sale
WEISMAN SCOTT director
Common Stock 1,900 $5.26 $9,994
Sale
KROIN DAVID director
Common Stock 5,467 $5.17 $28,264
Sale
KROIN DAVID director
Common Stock 10,000 $5.27 $52,700

Showing 250 to 300 of 458 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.